Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subhadeep Roy

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Breast Cancer (Tokyo, Japan)|August 26, 2016
DuCLOX-2/5 inhibition: a promising target for cancer chemopreventionSwetlana Gautam, Subhadeep Roy, Mohd Nazam Ansari, et al.
BMC Cancer|July 27, 2022
Correction: Repurposing mechanistic insight of PDE-5 inhibitor in cancer chemoprevention through mitochondrial-oxidative stress intervention and blockade of DuCLOX signallingManjari Singh, Sweta Kasna, Subhadeep Roy, et al.
BMC Cancer|October 26, 2019
Repurposing mechanistic insight of PDE-5 inhibitor in cancer chemoprevention through mitochondrial-oxidative stress intervention and blockade of DuCLOX signallingManjari Singh, Sweta Kasna, Subhadeep Roy, et al.
International Journal of Pharmaceutics|November 3, 2024
Leveraging solid solubility and miscibility of etoricoxib in Soluplus® towards manufacturing of 3D printed etoricoxib tablets by additive manufacturingMakka Krupali Ashokbhai, Shubham Ghatole, Ujjwal Gupta, et al.
International Journal of Pharmaceutics|June 10, 2026
Solvent-free engineering of a co-amorphous efavirenz-ritonavir system by hot-melt extrusion: Solid-state stabilisation and improved bioavailabilityShubham Ghatole, Koustav Taladhi, Mamta Kumari, et al.
Journal of Materials Chemistry. B|August 29, 2025
Hybrid photo-crosslinked decellularized extracellular matrix scaffold from porcine Achilles tendon: a biocompatible and non-immunogenic matrix for tissue engineeringShreeyash Shelar, Ujjwal Gupta, Mamta Kumari, et al.
Progress in Biomedical Engineering (Bristol, England)|December 11, 2024
Development of bioengineered 3D patient derived breast cancer organoid model focusing dynamic fibroblast-stem cell reciprocityNakka Sharmila Roy, Mamta Kumari, Kamare Alam, et al.
Cell Biochemistry and Function|April 6, 2019
Activation of prolyl hydroxylase-2 for stabilization of mitochondrial stress along with simultaneous downregulation of HIF-1α/FASN in ER + breast cancer subtypeUma Devi, Manjari Singh, Subhadeep Roy, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 2, 2024
A 3D in-vitro biomimicking Caco-2 intestinal permeability model-based assessment of physically modified telmisartan towards an alkalizer-free formulation developmentSunil Kumar Sah, Kamare Alam, Mamta Kumari, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 30, 2026
Mesalamine premix-based delayed release formulation and its efficacy assessment using a 3D in-vitro gut model for inflammatory bowel diseaseSunil Kumar Sah, Mamta Kumari, Lohare Rahul Sanjay, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Breast Cancer (Tokyo, Japan)|August 26, 2016
DuCLOX-2/5 inhibition: a promising target for cancer chemopreventionSwetlana Gautam, Subhadeep Roy, Mohd Nazam Ansari, et al.
BMC Cancer|July 27, 2022
Correction: Repurposing mechanistic insight of PDE-5 inhibitor in cancer chemoprevention through mitochondrial-oxidative stress intervention and blockade of DuCLOX signallingManjari Singh, Sweta Kasna, Subhadeep Roy, et al.
BMC Cancer|October 26, 2019
Repurposing mechanistic insight of PDE-5 inhibitor in cancer chemoprevention through mitochondrial-oxidative stress intervention and blockade of DuCLOX signallingManjari Singh, Sweta Kasna, Subhadeep Roy, et al.
International Journal of Pharmaceutics|November 3, 2024
Leveraging solid solubility and miscibility of etoricoxib in Soluplus® towards manufacturing of 3D printed etoricoxib tablets by additive manufacturingMakka Krupali Ashokbhai, Shubham Ghatole, Ujjwal Gupta, et al.
International Journal of Pharmaceutics|June 10, 2026
Solvent-free engineering of a co-amorphous efavirenz-ritonavir system by hot-melt extrusion: Solid-state stabilisation and improved bioavailabilityShubham Ghatole, Koustav Taladhi, Mamta Kumari, et al.
Journal of Materials Chemistry. B|August 29, 2025
Hybrid photo-crosslinked decellularized extracellular matrix scaffold from porcine Achilles tendon: a biocompatible and non-immunogenic matrix for tissue engineeringShreeyash Shelar, Ujjwal Gupta, Mamta Kumari, et al.
Progress in Biomedical Engineering (Bristol, England)|December 11, 2024
Development of bioengineered 3D patient derived breast cancer organoid model focusing dynamic fibroblast-stem cell reciprocityNakka Sharmila Roy, Mamta Kumari, Kamare Alam, et al.
Cell Biochemistry and Function|April 6, 2019
Activation of prolyl hydroxylase-2 for stabilization of mitochondrial stress along with simultaneous downregulation of HIF-1α/FASN in ER + breast cancer subtypeUma Devi, Manjari Singh, Subhadeep Roy, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 2, 2024
A 3D in-vitro biomimicking Caco-2 intestinal permeability model-based assessment of physically modified telmisartan towards an alkalizer-free formulation developmentSunil Kumar Sah, Kamare Alam, Mamta Kumari, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 30, 2026
Mesalamine premix-based delayed release formulation and its efficacy assessment using a 3D in-vitro gut model for inflammatory bowel diseaseSunil Kumar Sah, Mamta Kumari, Lohare Rahul Sanjay, et al.
Pageof 11